Timothy J Craig
Overview
Explore the profile of Timothy J Craig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
2459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Aygoren-Pursun E, Magerl M, Craig T, Manning M, Hummel N, et al.
Allergy Asthma Clin Immunol
. 2025 Mar;
21(1):10.
PMID: 40089800
Background: The goal of on-demand treatment for hereditary angioedema attacks is to halt attack progression to minimize morbidity and mortality. Four on-demand treatments have been approved thus far (ecallantide, icatibant,...
2.
Cohn D, Soteres D, Craig T, Lumry W, Magerl M, Riedl M, et al.
J Allergy Clin Immunol
. 2024 Dec;
155(3):726-739.
PMID: 39724968
Over the past 2 decades, guidelines for the on-demand treatment of hereditary angioedema attacks have undergone significant evolution. Early treatment guidelines, such as the Canadian 2003 International Consensus Algorithm, often...
3.
Deng E, Craig T, Nguyen D, Al-Shaikhly T
Allergy Asthma Proc
. 2024 Nov;
45(6):e93-e100.
PMID: 39517080
Sulfonamides are associated with severe cutaneous adverse reactions (SCARs). Coronavirus disease 2019 (COVID-19) triggers an immune response, which may increase the likelihood of developing a hypersensitivity reaction. We sought to...
4.
Staubach P, Tachdjian R, Li H, Hakl R, Aygoren-Pursun E, Wieman L, et al.
Clin Exp Allergy
. 2024 Oct;
54(12):1020-1023.
PMID: 39353415
No abstract available.
5.
Al-Shaikhly T, Al-Obaydi S, Craig T, Henao M
Transpl Infect Dis
. 2024 Aug;
26(5):e14355.
PMID: 39136148
Background: While a penicillin allergy label has been linked to various negative clinical outcomes, limited studies have specifically characterized the implication of sulfonamide allergy labels (SAL) on clinical outcomes. We...
6.
Long L, Fujioka T, Craig T, Hitomi H
Asian Pac J Allergy Immunol
. 2024 Jun;
42(3):222-232.
PMID: 38877850
Hereditary angioedema (HAE) is a rare hereditary disorder characterized by episodic swelling and life-threatening airway obstruction caused by laryngeal angioedema. In most HAE patients, reduced level of serum C1-Inhibitor (type-I-HAE)...
7.
Stone S, Henao M, Craig T, Al-Shaikhly T
Pulm Ther
. 2024 May;
10(2):225-236.
PMID: 38782820
Introduction: The presence of antibiotic allergy labels can have harmful impacts on clinical outcomes, particularly among immunosuppressed patients, in whom there have been associations with increased complications, readmission rates, and...
8.
Craig T, Levy D, Reshef A, Lumry W, Martinez-Saguer I, Jacobs J, et al.
Lancet Haematol
. 2024 May;
11(6):e436-e447.
PMID: 38710185
Background: Garadacimab is a fully human immunoglobulin G4 monoclonal antibody targeting activated factor XII. This study evaluated long-term efficacy, health-related quality of life (HRQoL), and safety data for garadacimab in...
9.
Al-Shaikhly T, Norris M, Dennis E, Liu G, Craig T
J Allergy Clin Immunol Pract
. 2024 Feb;
12(6):1558-1567.
PMID: 38423294
Background: Biologic modifiers targeting type 2 (T2) airway inflammation are effective in reducing asthma exacerbation. However, real-world and comparative effectiveness studies remain limited. Objective: To examine and compare the real-world...
10.
Petersen R, Bordone L, Riedl M, Tachdjian R, Craig T, Lumry W, et al.
Allergy
. 2023 Nov;
79(3):724-734.
PMID: 38009241
Background: Hereditary angioedema (HAE) is a potentially fatal disease characterized by unpredictable, recurrent, often disabling swelling attacks. In a randomized phase 2 study, donidalorsen reduced HAE attack frequency and improved...